Inflammation
An MRI Guided Treat-To-Target Strategy in Rheumatoid Arthritis Patients in Clinical Remission Improved MRI Inflammation but Not Damage Progression – Results from the Imagine-RA Randomised Controlled Trial
The Value of Adding MRI to a Clinical Treat-To-Target Strategy in Rheumatoid Arthritis Patients in Clinical Remission: Clinical and Radiographic Outcomes from the Imagine-RA Randomised Controlled Trial
Safety and Efficacy of Lutikizumab (ABT-981), An Anti–Interleukin-1 Alpha/Beta Dual Variable Domain (DVD) Immunoglobulin, in Subjects with Knee Osteoarthritis: Results from the Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Trial
Dose Tapering and Discontinuation of Biological Therapy in Rheumatoid Arthritis Patients in Remission in Routine Care – 2-Year Outcomes and Identification of Predictors
Delayed Gadolinium Enhanced MRI of Menisci and Cartilage (dGEMRIM/dGEMRIC) In Overweight Patients With Knee Osteoarthritis
Quantitative MRI of Single Vs. Multiple Joints in Juvenile Idiopathic Arthritis as Predictive Measure of Clinical Outcomes
Dynamic Contrast Enhanced (DCE)-MRI in Relation To Inflammatory Markers in Serum and Joint Fluid: Initial Data and Validation in Four Most Common Knee Arthritic Diseases
Rheumatoid arthritis: what do MRI and ultrasound show
Synovial Explant Inflammatory Mediator Production is Correlated with Disease Activity in Rheumatoid Arthritis: A Cross Sectional Study
Maecenas tempor, ex at maximus efficitur, felis sem ultrices ligula, ut hendrerit purus eros ac urna. Vestibulum ut vestibulum tortor. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cras eu lectus quam. Nunc ligula arcu, auctor sit amet tellus eleifend, facilisis laoreet odio. Donec placerat urna eleifend blandit porttitor.
Nunc magna turpis, tristique at dictum vel, sollicitudin blandit felis. Morbi aliquam elit et pellentesque vulputate. Donec elementum, ante quis ornare porttitor, tortor dolor vestibulum velit, et viverra enim massa vitae ex.
